Pfizer plant in Australia set to be axed

Pfizer ($PFE), which has been shedding plants around the world, has targeted another one. The U.S. drugmaker will close a plant in Sydney, Australia, in 2015, whacking 140 jobs. Workers were told that Pfizer needs less capacity as it moves toward more targeted drugs. In May it agreed to sell a plant in Bristol, TN, and it has announced cuts in Ireland, although it also recently said it will expand a couple of facilities there. Report | More

Suggested Articles

Turns out Procter & Gamble didn’t want Pfizer’s consumer health unit after all. But it did want Merck KGaA’s.

Private equity firm, in exclusive talks with Sanofi, says it'll invest to pump up Zentiva into an "independent European generics leader."

With suitor Takeda circling Shire, the Dublin-based target has pulled off a deal of its own.